Investigations of clandestine drug manufacturing laboratories

Terry A. Dal Cason , Charlotte A. Corbett , Peter K. Poole , James A. de Haseth , David K. Gouldthorpe. Forensic Science International 2012 223 (1-3), 279-291 ...

3 days ago - Biocatalytic continuous manufacturing of diabetes drug: plantwide process modeling, optimization, environmental and economic analysis.

Pharmacophore-Guided Drug Discovery Investigations Leading to Bioactive. 5-Aminotetrahydropyrazolopyridines. Implications for the Binding Mode of.

Aug 11, 2005 - The results indicate that the sp2 nitrogens of the pyrazole and thiazole rings of the dopaminergics (S)-1 and pramipexole, respectively, are pharmacophoric elements of major importance. To provide putative explanations for the high aff

May 26, 2014 - Researchers take to papers, social media to debate whether striped coatings on nanoparticles exist. 40 CONCENTRATES. 33 CHINESE COAL GIANT ... consolidation is snapped up by chemical firms. 27 INTO THEIR OWN HANDS. Patient groups are f

Impressive advances in producing enantiomeric intermediates have been fashioned by a number of research groups. Such advances are increasingly important ...

May 26, 2014 - Forceful critique greets EPA's proposed new rules on fence-line toxics at petrochemical plants. 9. SCIENCE BY THE INTERACTIVE NUMBERS.

Air-Conditioning in the Drug-Manufacturing Industry. William A. Hanley. Ind. Eng. Chem. , 1933, 25 (1), pp 9–12. DOI: 10.1021/ie50277a003. Publication Date: ...

Apr 28, 2007 - Artemisinin and its derivatives, such as artemether, are highly sensitive compounds, which require careful optimized production processes for their manufacture. Due to robustness issues, the manufacturing procedure of the reduction of

Apr 28, 2007 - Novartis Pharma AG, Chemical and Analytical Development, CH-4002 Basel, Switzerland. Org. Process Res. Dev. , 2007, 11 (3), pp 341–345.